197
Participants
Start Date
July 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
CP-690,550
tablets, 2 mg BID for 12 weeks
CP-690,550
tablets, 5 mg BID for 12 weeks
CP-690,550
tablets, 15 mg BID for 12 weeks
Placebo
tablets, BID for 12 weeks
Pfizer Investigational Site, New York
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Norfolk
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Mt. Pleasant
Pfizer Investigational Site, Greer
Pfizer Investigational Site, Greer
Pfizer Investigational Site, Jacksonville
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, West Dundee
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Norman
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Webster
Pfizer Investigational Site, Salt Lake City
Pfizer Investigational Site, Tucson
Pfizer Investigational Site, Oceanside
Pfizer Investigational Site, Lake Oswego
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Worcester
Pfizer Investigational Site, East Windsor
Pfizer Investigational Site, Paramus
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, Moncton
Pfizer Investigational Site, St. John's
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Barrie
Pfizer Investigational Site, London
Pfizer Investigational Site, North Bay
Pfizer Investigational Site, Waterloo
Pfizer Investigational Site, Windsor
Pfizer Investigational Site, Laval
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Québec
Lead Sponsor
Pfizer
INDUSTRY